Carrier of human T-lymphotropic virus type- 1 [HTLV-1] infection
Conditions
Interventions
They will be divided into two groups of 8 subjects each group, totaling 16 volunteers at the end of the research. The treatment will be performed in 15 sessions, 3 times a week, for a total of 5 weeks
active exercises divided into 3 sets of 10 repetitions for lower limbs (consisting of maintaining a fully extended lower limb and raising it to the knee height of the contralateral lower limb, which w
core abdominal (bridge exercises)
proprioceptive neuromuscular facilitation (PNF), with one diagonal for the lower limbs and one for the trunk
and balance training by positioning the feet to reduce the footing, performing 3 sets of 30 seconds each, expected to last 30 minutes. After applying this protocol, the experimental group will perform
Other
Z22.6
E02.760.169.063.500
L01.224.160.875
Sponsors
Núcleo de Medicina Tropical
Núcleo de Medicina Tropical
Eligibility
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Have the confirmed diagnosis of PET / MAH, by an infectologist; refer to mild pain or acute second visual analogue scale (VAS); gait alteration (claudication, use of orthoses as a cane or crutch) and age range between 30 and 60 years.
Exclusion criteria
Exclusion criteria: Have less than 6 months of PET / MAH diagnosis; have any other neurological diagnosis; use wheelchair; being physio-therapeutic treatment concomitantly to the period of the research; does not meet the inclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary end point is to compare whether virtual reality associated with conventional physical therapy treatment provided a greater effect than conventional treatment associated with placebo, in the balance of these patients with pet / mah, compared between the moments before and after application of the protocols. As an evaluation method, the force platform will be used, an instrument that measures the center of pressure, and from the collected data, it is possible to verify the displacement area, velocity and amplitude, for example. In addition to the platform, a miniBESTest clinical assessment scale will also be used, which assesses balance through predetermined tasks and scores them between 0 and 2, with a total of 14 questions, reaching 28 points. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome aims to verify whether the virtual reality associated with conventional physical therapy treatment provided a superior effect to conventional treatment associated with placebo, in the quality of life and pain of these patients with pet / mah, compared between the pre and post application of the protocols. For this evaluation, a clinical scale called short-form 36 or SF-36 will be used, which measures domains such as functional capacity, physical aspects, pain, general health status, vitality, social aspects, emotional aspects and mental health. The scale ranges from 0 to 100 in each of the domains, with the highest values related to improvement. | — |
Countries
Brazil
Contacts
Public ContactAlex Viana da Cruz
Núcleo de Medicina Tropical
Outcome results
None listed